IL18 and colitis: Others have shown that 2,4,6-trinitrobenzene sulfonic acid (TNBSA) was unable to induce significant colitis in IL-18 deficient mice and that administration of an IL-18 neutralizing antibody resulted in a dramatic attenuation of mucosal inflammation.